A primary, structural driver of the sustained growth in the In Vitro Diagnostics (IVD) Market is the escalating global prevalence of chronic diseases coupled with the rapid aging of the population. As populations age, the incidence of conditions such as diabetes, cardiovascular disease (CVD), chronic kidney disease (CKD), and various cancers increases exponentially. These diseases are not...

The global point of care diagnostics market size was accounted for USD 54.68 billion in 2024 and is expected to hit around USD 129.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.04% from 2025 to 2034. The market research report on the Point of Care Diagnostics Market industry provides crucial insights into current growth trends and primary revenue drivers...

The Cardiac Marker Market continues to gain critical momentum as healthcare systems worldwide intensify efforts toward early detection and personalized management of cardiovascular diseases (CVDs). With cardiovascular conditions remaining a leading cause of morbidity and mortality, the rise of advanced cardiac biomarkers, integrated diagnostics, and AI-enabled point-of-care solutions is...

The Triage B-Type Natriuretic Peptide (BNP) Testing Market is a critical segment within the in-vitro diagnostics industry, driven primarily by the escalating global prevalence of Cardiovascular Diseases (CVDs), particularly Congestive Heart Failure (CHF). BNP is a key biomarker released by the cardiac ventricles in response to myocardial wall stress, making its measurement...